News-Medical.Net on MSN

Incretin-based diabetes drugs show potential protective effects against dementia

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...
TAG24 on MSN

London scientists make progress with figuring out Alzheimer's cause

British scientists have made a potentially important discovery related to dementia and Alzheimer’s disease that could pave ...
Cantech Letter

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem cell company treating those who suffer in pain ...
The Malaysian Reserve

New clinical data highlights CAPLYTA® (lumateperone) as a promising option for achieving remission in adults with major depressive disorder

CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled data ...
News-Medical.Net on MSN

Repurposed Alzheimer’s medication offers low-cost hope for sickle cell anemia

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, ...